PathologyFrontiers in PharmacologyPeer-reviewed
CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in murine model of the SARS-CoV-2-related acute respiratory distress syndrome
А. С. Чернов, Maksim V. Rodionov, Vitaly A. Kazakov…·Alexey A. Belogurov
This paper shows that TAK-779, a CCR5/CXCR3 antagonist, prevents diffuse alveolar damage in a murine model of SARS-CoV-2-induced ARDS by reducing mononuclear infiltration and cytokine levels.
13 citations